Catalent Pharma News
Most Popular Catalent Pharma Story
ALSO NOTED: Rebif gets EU nod; Bayer buys Citracal;
> Merck Serono got the EU nod to market a new version of the relapsing multiple sclerosis med Rebif. The new formulation, designed to be better tolerated when injected, will launch next month;... Read more...
Latest Headlines
- August 30, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
